On Wednesday, Cronos Group announced the closing of a bought deal financing that saw the company raise approximately $46-million. The offering was underwritten by a syndicate led by PI Financial Corp. and included GMP Securities, Beacon Securities, and Cormark Securities.
In a research update to clients today, Landry resumed coverage of the stock. The analyst simultaneously raised his price target on Cronos, from $4.50 to $11.00, but lowered his rating on it, from “Buy” to “Hold”. His new target implied a return of 1.5 per cent at the time of publication.
Landry says there is a lot to like about Cronos, just not at its current share price, which has more than quadrupled since September.
“We like MJN’s growth profile with a large domestic capacity expansion, and a strong international platform, the analyst says. “However with shares trading at ~17x CY19 sales, MJN’s valuation is the highest amongst peers under coverage based on our forecasts, and adequately reflects the bright outlook. Hence our downgrade is mainly based on valuation which we would revisit pending a pullback in share price. Our target is based on a DCF using: 1) a discount rate of 9.5% (10% prior), (2) avg. market share of 4% and avg. EBITDA margin of 30% (32% prior), and (3) terminal growth of 3%.
Landry thinks Cronos Group will generate EBITDA of negative $3.2-million on revenue of $4.5-million in fiscal 2017. He expects those numbers will improve to EBITDA of positive $19.2-million on a topline of $64.3-million the following year.
On Sept. 12, Ventum Capital Markets analyst Rob Goff cut his target price for NowVertical Group (NowVertical Group Stock Quote,… [Read More]
In a Sept. 11 report, Roth Capital Markets analyst Sean McGowan raised his 12-month target price on GURU Organic Energy… [Read More]
Canadian household balance sheets remained resilient in the second quarter of 2025, with net worth edging higher despite elevated debt-servicing… [Read More]
Haywood Capital Markets analyst Neal Gilmer initiated coverage on High Tide (High Tide Stock Quote, Chart, News, Analysts, Financials TSXV:HITI)… [Read More]
TD Cowen analyst David Kwan maintained a “Buy” rating and C$7.50 target price on WELL Health Technologies (WELL Health Stock… [Read More]
Linde Equity Fund analyst Teal Linde told BNN Bloomberg’s Market Watch on Sept. 8 that Pinterest (Pinterest Stock Quote, Chart,… [Read More]